Tylvalosin tartrate
Cat. No.：YN250409
CAS No. ：63428-13-7
| 产品名称: | Tylvalosin tartrate |
| CAS No.: | 63428-13-7 |
| Chemical Name: | 3-acetate 4B-(3-methylbutanoate)tylosin, 2R,3R-dihydroxybutanedioate |
| Synonyms: | Acetylisovaleryltylosin tartrate |
| 分子量: | 1192.34 |
| 分子式: | C₅₇H₉₃NO₂₅ |
| SMILES: | OC([C@H](O)[C@@H](O)C(O)=O)=O.O[C@@H]1[C@@H](C)O[C@@H](OC[C@H]([C@@H](CC)OC(C[C@@H](OC(C)=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@@H]3O[C@@H](C)[C@H](OC(CC(C)C)=O)[C@@](O)(C)C3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@H]4C)=O)/C=C(C)/C=C/C4=O)[C@H](OC)[C@ |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Tylvalosin tartrate (Acetylisovaleryltylosin tartrate) 是一种大环内酯类抗生素，对革兰氏阳性细菌具有抗性 (Gram-positive bacteria)。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Yang, B., Lei, Z., Zhao, Y., et al.Combination susceptibility testing of common antimicrobials in vitro and the effects of sub-MIC of antimicrobials on Staphylococcus aureus biofilm formationFront. Microbiol.8,2125(2017)
Zhao, Z., Tang, X., Zhao, X., et al.Tylvalosin exhibits anti-inflammatory property and attenuates acute lung injury in different models possibly through suppression of NF-κB activationBiochem. Pharmacol.90(1),73-87(2014)
Lopez Rodriguez, A., Berge, A.C., Ramage, C., et al.Evaluation of the clinical efficacy of a water soluble formulation of tylvalosin in the control of enzootic pneumonia associated with Mycoplasma hyopneumoniae and Pasteurella multocida in pigsPorcine Health Manag.6(1),39(2020)
